Healthcare - Biotechnology - NASDAQ - FR
$ 1.44
-11.7 %
$ 117 M
Market Cap
-3.27
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
28.02%
EBIT
Estimate
--45.81%
Net Income
Estimate
49.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Innate Pharma S.A.
IPHA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart IPHA
EBIT FORECAST
EBIT Forecast Chart IPHA
NET INCOME FORECAST
Net Income Chart IPHA